Loading clinical trials...
Loading clinical trials...
The primary objective of the LEVANT 2 Extended Follow-up Post-Approval Study (PAS 1) is to evaluate the long-term performance of the Lutonix Drug Coated Balloon (DCB) versus Percutaneous Transluminal ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
C. R. Bard
NCT05624125 · Peripheral Artery Disease
NCT04584632 · Peripheral Arterial Disease, Vascular Diseases, and more
NCT06212271 · Peripheral Artery Disease
NCT07283289 · Peripheral Artery Disease
NCT06003855 · Peripheral Artery Disease
Mission Cardiovascular Research Institute
Fremont, California
Metro Health Hospital
Wyoming, Michigan
Jackson Heart Clinic/St. Dominic's Hospital
Jackson, Mississippi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions